Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
The interest coverage ratio is -22.81x as of the fiscal period ended Tuesday, March 31, 2026.
Reported quarterly interest coverage; no daily interpolation. Q1 FY2026 (2026-03-31): -22.81x.
INTEREST COVERAGE RATIO
-22.81x
INTEREST COVERAGE RATIO AVG TTM
N/A
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
-827.80x
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
+97.24%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.44x
median of 527 covered companies
CURRENT VS SECTOR MEDIAN
-254.14%
vs the sector median at left
Market Cap
$1.89B
Interest Coverage Ratio
-0.40x
TTM Avg
732.40x
3Y Avg
732.40x
5Y Avg
732.40x
Market Cap
$1.89B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.87B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.86B
Interest Coverage Ratio
24.98x
TTM Avg
24.98x
3Y Avg
24.98x
5Y Avg
24.98x
Market Cap
$1.92B
Interest Coverage Ratio
-1.54x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.94B
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.84B
Interest Coverage Ratio
-6.63x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Zymeworks Inc. (ZYME) | $1.89B | -22.81x | N/A | N/A | N/A |
| BioLife Solutions, Inc. (BLFS)vs › | $1.89B | -0.40x | 732.40x | 732.40x | 732.40x |
| Agios Pharmaceuticals, Inc. (AGIO)vs › | $1.89B | N/A | N/A | N/A | N/A |
| Trevi Therapeutics, Inc. (TRVI)vs › | $1.87B | N/A | N/A | N/A | N/A |
| Novavax, Inc. (NVAX)vs › | $1.86B | 24.98x | 24.98x | 24.98x | 24.98x |
| Establishment Labs Holdings Inc. (ESTA)vs › | $1.92B | -1.54x | N/A | N/A | N/A |
| Immunome, Inc. (IMNM)vs › | $1.85B | N/A | N/A | N/A | N/A |
| Mineralys Therapeutics, Inc. (MLYS)vs › | $1.94B | N/A | N/A | N/A | N/A |
| Palvella Therapeutics, Inc. (PVLA)vs › | $1.84B | -6.63x | N/A | N/A | N/A |
| Astrana Health, Inc. (ASTH)vs › | $1.83B | 1.57x | 2.14x | 5.67x | 7.21x |
Interest Coverage
-22.8x
Debt/Equity
3.34
Current Ratio
6.32
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2026-03-31 | -22.81x |
| 2019-09-30 | -2237.60x |
| 2019-06-30 | -452.80x |
| 2019-03-31 | -4851.00x |
| 2018-09-30 | -117.68x |
| 2018-06-30 | -403.20x |
| 2018-03-31 | -2513.88x |
| 2017-12-31 | 68.88x |
| 2017-09-30 | -8348.50x |
| 2017-06-30 | -51.58x |
| 2017-03-31 | -72.27x |
| 2016-12-31 | -52.43x |
| 2016-09-30 | -41.55x |
| 2016-06-30 | -13.56x |
| 2016-03-31 | -9739.00x |
